Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgery | 48 | 2025 | 143 | 16.710 |
Why?
|
| Global Health | 24 | 2024 | 213 | 7.290 |
Why?
|
| Neurosurgeons | 33 | 2025 | 45 | 5.750 |
Why?
|
| Neurosurgical Procedures | 30 | 2025 | 356 | 4.450 |
Why?
|
| Neural Tube Defects | 7 | 2024 | 46 | 3.120 |
Why?
|
| Physicians, Women | 8 | 2021 | 61 | 2.590 |
Why?
|
| Spinal Dysraphism | 5 | 2024 | 29 | 2.150 |
Why?
|
| World Health Organization | 6 | 2024 | 122 | 2.130 |
Why?
|
| Food, Fortified | 9 | 2024 | 18 | 1.790 |
Why?
|
| Colonialism | 2 | 2024 | 2 | 1.680 |
Why?
|
| Internship and Residency | 9 | 2025 | 1134 | 1.670 |
Why?
|
| Hematoma, Subdural, Chronic | 2 | 2021 | 3 | 1.410 |
Why?
|
| Anencephaly | 4 | 2023 | 7 | 1.370 |
Why?
|
| Developing Countries | 5 | 2024 | 91 | 1.130 |
Why?
|
| Humans | 94 | 2025 | 95802 | 1.100 |
Why?
|
| Folic Acid | 8 | 2023 | 63 | 1.050 |
Why?
|
| Brain Neoplasms | 9 | 2023 | 848 | 1.010 |
Why?
|
| History, 21st Century | 11 | 2025 | 192 | 1.010 |
Why?
|
| History, 20th Century | 11 | 2025 | 327 | 0.970 |
Why?
|
| Endoscopy | 4 | 2015 | 374 | 0.960 |
Why?
|
| Sphenoid Bone | 3 | 2014 | 9 | 0.940 |
Why?
|
| Leadership | 2 | 2024 | 159 | 0.880 |
Why?
|
| Pituitary Neoplasms | 4 | 2015 | 74 | 0.840 |
Why?
|
| Curriculum | 3 | 2024 | 615 | 0.830 |
Why?
|
| Micronutrients | 1 | 2024 | 18 | 0.820 |
Why?
|
| Spina Bifida Cystica | 1 | 2023 | 1 | 0.800 |
Why?
|
| Hemostasis, Surgical | 1 | 2023 | 25 | 0.790 |
Why?
|
| Periodicals as Topic | 2 | 2022 | 171 | 0.780 |
Why?
|
| Delivery of Health Care | 3 | 2024 | 468 | 0.780 |
Why?
|
| Transition to Adult Care | 1 | 2023 | 23 | 0.780 |
Why?
|
| Hemostatics | 1 | 2023 | 61 | 0.770 |
Why?
|
| International Cooperation | 4 | 2024 | 134 | 0.740 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 172 | 0.700 |
Why?
|
| Conservative Treatment | 1 | 2021 | 27 | 0.690 |
Why?
|
| Risk Adjustment | 1 | 2021 | 40 | 0.690 |
Why?
|
| Medical Illustration | 1 | 2021 | 17 | 0.680 |
Why?
|
| Surgeons | 2 | 2024 | 298 | 0.670 |
Why?
|
| Craniotomy | 1 | 2021 | 97 | 0.660 |
Why?
|
| Consultants | 1 | 2020 | 7 | 0.650 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 398 | 0.620 |
Why?
|
| Cultural Diversity | 1 | 2020 | 68 | 0.620 |
Why?
|
| Africa | 3 | 2024 | 107 | 0.610 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2023 | 125 | 0.440 |
Why?
|
| Societies, Medical | 1 | 2018 | 644 | 0.430 |
Why?
|
| Sports | 1 | 2014 | 40 | 0.420 |
Why?
|
| HIV Infections | 1 | 2023 | 974 | 0.410 |
Why?
|
| Brain Concussion | 1 | 2014 | 88 | 0.400 |
Why?
|
| Athletic Injuries | 1 | 2014 | 103 | 0.390 |
Why?
|
| Nasal Cavity | 1 | 2013 | 94 | 0.390 |
Why?
|
| Neuronavigation | 1 | 2012 | 25 | 0.380 |
Why?
|
| Neuroendoscopy | 1 | 2012 | 21 | 0.380 |
Why?
|
| Trigeminal Neuralgia | 1 | 2011 | 8 | 0.360 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2011 | 7 | 0.360 |
Why?
|
| Adenoma | 2 | 2015 | 260 | 0.350 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 378 | 0.340 |
Why?
|
| Politics | 1 | 2011 | 53 | 0.340 |
Why?
|
| Neurology | 1 | 2011 | 83 | 0.320 |
Why?
|
| Greece | 3 | 2025 | 20 | 0.320 |
Why?
|
| Surgical Flaps | 2 | 2010 | 259 | 0.320 |
Why?
|
| Clinical Competence | 3 | 2024 | 854 | 0.320 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2010 | 11 | 0.310 |
Why?
|
| Meningioma | 4 | 2003 | 68 | 0.310 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2010 | 20 | 0.310 |
Why?
|
| Quality of Life | 5 | 2023 | 1816 | 0.310 |
Why?
|
| Students, Medical | 3 | 2024 | 455 | 0.300 |
Why?
|
| Surgical Instruments | 2 | 2023 | 63 | 0.290 |
Why?
|
| Prevalence | 5 | 2024 | 1349 | 0.290 |
Why?
|
| Education, Medical | 2 | 2022 | 252 | 0.290 |
Why?
|
| Female | 26 | 2024 | 49872 | 0.280 |
Why?
|
| Certification | 2 | 2024 | 66 | 0.270 |
Why?
|
| Pandemics | 3 | 2023 | 880 | 0.260 |
Why?
|
| Europe | 6 | 2024 | 349 | 0.250 |
Why?
|
| Emigration and Immigration | 2 | 2024 | 49 | 0.250 |
Why?
|
| Cavernous Sinus | 2 | 1999 | 15 | 0.230 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 2859 | 0.230 |
Why?
|
| Pituitary Gland | 3 | 2015 | 118 | 0.230 |
Why?
|
| Academies and Institutes | 1 | 2025 | 34 | 0.220 |
Why?
|
| Bibliometrics | 2 | 2022 | 46 | 0.220 |
Why?
|
| Transportation of Patients | 1 | 2025 | 35 | 0.220 |
Why?
|
| Capacity Building | 1 | 2024 | 12 | 0.220 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2024 | 50 | 0.220 |
Why?
|
| Aged | 10 | 2023 | 20848 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 2773 | 0.220 |
Why?
|
| Air Ambulances | 1 | 2025 | 31 | 0.220 |
Why?
|
| Stakeholder Participation | 1 | 2024 | 24 | 0.210 |
Why?
|
| Income | 2 | 2021 | 90 | 0.210 |
Why?
|
| Patient Transfer | 1 | 2025 | 108 | 0.210 |
Why?
|
| Nose | 2 | 2015 | 96 | 0.200 |
Why?
|
| Eponyms | 1 | 2023 | 1 | 0.200 |
Why?
|
| Career Choice | 2 | 2024 | 163 | 0.200 |
Why?
|
| Child | 7 | 2023 | 7618 | 0.200 |
Why?
|
| Forecasting | 2 | 2021 | 317 | 0.190 |
Why?
|
| Travel | 1 | 2023 | 73 | 0.190 |
Why?
|
| Radiosurgery | 4 | 2011 | 316 | 0.180 |
Why?
|
| Education, Distance | 1 | 2022 | 25 | 0.180 |
Why?
|
| Law Enforcement | 1 | 2021 | 12 | 0.180 |
Why?
|
| Motorcycles | 1 | 2021 | 12 | 0.180 |
Why?
|
| Djibouti | 1 | 2021 | 1 | 0.180 |
Why?
|
| Head Protective Devices | 1 | 2021 | 23 | 0.170 |
Why?
|
| Microsurgery | 4 | 2015 | 99 | 0.170 |
Why?
|
| Australasia | 1 | 2021 | 4 | 0.170 |
Why?
|
| Middle East | 1 | 2021 | 19 | 0.170 |
Why?
|
| Craniocerebral Trauma | 1 | 2021 | 60 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1878 | 0.170 |
Why?
|
| Asia | 1 | 2021 | 105 | 0.170 |
Why?
|
| Language | 1 | 2022 | 162 | 0.170 |
Why?
|
| Health Resources | 1 | 2021 | 82 | 0.170 |
Why?
|
| Internet | 2 | 2014 | 340 | 0.160 |
Why?
|
| Accidents, Traffic | 1 | 2021 | 104 | 0.160 |
Why?
|
| Time | 1 | 2020 | 79 | 0.160 |
Why?
|
| Italy | 1 | 2020 | 112 | 0.160 |
Why?
|
| Meningeal Neoplasms | 2 | 1999 | 73 | 0.160 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 436 | 0.160 |
Why?
|
| Male | 19 | 2024 | 45686 | 0.160 |
Why?
|
| Health Equity | 1 | 2022 | 103 | 0.160 |
Why?
|
| Adult | 15 | 2024 | 28578 | 0.150 |
Why?
|
| Decompressive Craniectomy | 1 | 2019 | 22 | 0.150 |
Why?
|
| Volunteers | 2 | 2020 | 22 | 0.150 |
Why?
|
| Intersectoral Collaboration | 1 | 2018 | 11 | 0.140 |
Why?
|
| Skull Base Neoplasms | 1 | 1999 | 17 | 0.140 |
Why?
|
| Vitamin B Complex | 1 | 2018 | 21 | 0.140 |
Why?
|
| Skull Neoplasms | 2 | 1996 | 27 | 0.140 |
Why?
|
| Tissue Adhesives | 2 | 2010 | 24 | 0.140 |
Why?
|
| Intracranial Hypertension | 1 | 2019 | 60 | 0.140 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2019 | 80 | 0.140 |
Why?
|
| Advisory Committees | 1 | 2018 | 94 | 0.140 |
Why?
|
| Registries | 2 | 2023 | 985 | 0.140 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 128 | 0.130 |
Why?
|
| Patient Selection | 1 | 2021 | 708 | 0.130 |
Why?
|
| Public Health | 3 | 2023 | 155 | 0.130 |
Why?
|
| Physician's Role | 1 | 2018 | 186 | 0.130 |
Why?
|
| Endoscopes | 2 | 2013 | 10 | 0.130 |
Why?
|
| Anesthesiology | 1 | 2018 | 168 | 0.120 |
Why?
|
| Adolescent | 4 | 2023 | 9873 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2021 | 2592 | 0.110 |
Why?
|
| Nose Diseases | 1 | 2015 | 9 | 0.110 |
Why?
|
| Physicians | 1 | 2022 | 706 | 0.110 |
Why?
|
| Young Adult | 3 | 2024 | 7026 | 0.110 |
Why?
|
| Search Engine | 1 | 2014 | 12 | 0.110 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2011 | 52 | 0.110 |
Why?
|
| Foundations | 1 | 2014 | 15 | 0.110 |
Why?
|
| Paranasal Sinuses | 1 | 2015 | 62 | 0.110 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 41 | 0.110 |
Why?
|
| Diagnosis, Differential | 4 | 2011 | 1615 | 0.100 |
Why?
|
| Optic Nerve | 1 | 2013 | 36 | 0.100 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1993 | 5 | 0.100 |
Why?
|
| Health Literacy | 1 | 2014 | 77 | 0.100 |
Why?
|
| Cochlea | 1 | 1993 | 50 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 1993 | 52 | 0.100 |
Why?
|
| Skull Base | 1 | 2013 | 52 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 2013 | 136 | 0.090 |
Why?
|
| Hydrocephalus | 2 | 1992 | 108 | 0.090 |
Why?
|
| Fetal Diseases | 1 | 1992 | 81 | 0.090 |
Why?
|
| User-Computer Interface | 1 | 2013 | 196 | 0.090 |
Why?
|
| Rhizotomy | 1 | 2011 | 1 | 0.090 |
Why?
|
| Trigeminal Nerve | 1 | 2011 | 18 | 0.090 |
Why?
|
| Sella Turcica | 1 | 2011 | 17 | 0.090 |
Why?
|
| War Crimes | 1 | 2011 | 2 | 0.090 |
Why?
|
| Tunisia | 1 | 2011 | 7 | 0.090 |
Why?
|
| Egypt | 1 | 2011 | 14 | 0.090 |
Why?
|
| Warfare | 1 | 2011 | 12 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1992 | 155 | 0.090 |
Why?
|
| Information Systems | 1 | 2011 | 30 | 0.090 |
Why?
|
| Gait | 1 | 2011 | 85 | 0.090 |
Why?
|
| Pentetic Acid | 1 | 1991 | 25 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2011 | 199 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2015 | 9167 | 0.080 |
Why?
|
| Chordoma | 1 | 2011 | 42 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2011 | 126 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 168 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2013 | 1158 | 0.080 |
Why?
|
| Illinois | 1 | 2011 | 530 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 1991 | 148 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 514 | 0.080 |
Why?
|
| Radiography | 1 | 2011 | 823 | 0.080 |
Why?
|
| Consensus | 2 | 2023 | 370 | 0.080 |
Why?
|
| Dementia | 1 | 2011 | 218 | 0.070 |
Why?
|
| Software | 1 | 2013 | 698 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 1996 | 3639 | 0.070 |
Why?
|
| Personnel Selection | 1 | 2008 | 64 | 0.070 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2007 | 23 | 0.070 |
Why?
|
| Osteomyelitis | 1 | 2007 | 57 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2023 | 4664 | 0.060 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2007 | 29 | 0.060 |
Why?
|
| Prognosis | 2 | 2011 | 3990 | 0.060 |
Why?
|
| Scalp | 1 | 2007 | 72 | 0.060 |
Why?
|
| Middle Aged | 9 | 2015 | 28208 | 0.060 |
Why?
|
| Risk Factors | 2 | 2021 | 5961 | 0.060 |
Why?
|
| Dura Mater | 1 | 2007 | 51 | 0.060 |
Why?
|
| Suture Techniques | 1 | 2007 | 143 | 0.060 |
Why?
|
| History, 15th Century | 1 | 2025 | 5 | 0.060 |
Why?
|
| History, 16th Century | 1 | 2025 | 8 | 0.060 |
Why?
|
| History, 17th Century | 1 | 2025 | 12 | 0.060 |
Why?
|
| History, Medieval | 1 | 2025 | 13 | 0.060 |
Why?
|
| History, 18th Century | 1 | 2025 | 22 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2007 | 192 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2025 | 59 | 0.060 |
Why?
|
| History, Ancient | 1 | 2025 | 81 | 0.060 |
Why?
|
| Moldova | 1 | 2024 | 1 | 0.060 |
Why?
|
| Anniversaries and Special Events | 1 | 2024 | 16 | 0.050 |
Why?
|
| Serbia | 1 | 2024 | 3 | 0.050 |
Why?
|
| Incidence | 2 | 2019 | 1714 | 0.050 |
Why?
|
| Turkey | 1 | 2024 | 22 | 0.050 |
Why?
|
| Patient Advocacy | 1 | 2024 | 64 | 0.050 |
Why?
|
| Therapies, Investigational | 1 | 2023 | 18 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 82 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 89 | 0.050 |
Why?
|
| Policy | 1 | 2023 | 42 | 0.050 |
Why?
|
| Afghanistan | 1 | 2022 | 3 | 0.050 |
Why?
|
| Brain | 2 | 2011 | 2480 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2023 | 3106 | 0.050 |
Why?
|
| Iceland | 1 | 2022 | 20 | 0.050 |
Why?
|
| Democratic Republic of the Congo | 1 | 2022 | 8 | 0.050 |
Why?
|
| Canada | 1 | 2023 | 214 | 0.050 |
Why?
|
| Sexism | 1 | 2023 | 57 | 0.050 |
Why?
|
| Survival Rate | 2 | 1999 | 1971 | 0.040 |
Why?
|
| Protective Factors | 1 | 2021 | 28 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2023 | 404 | 0.040 |
Why?
|
| Policy Making | 1 | 2021 | 63 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 14 | 0.040 |
Why?
|
| United States | 3 | 2022 | 7764 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 2020 | 17 | 0.040 |
Why?
|
| Pregnancy | 2 | 2022 | 3237 | 0.040 |
Why?
|
| Journal Impact Factor | 1 | 2020 | 15 | 0.040 |
Why?
|
| Olfactory Bulb | 1 | 2000 | 42 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2003 | 1535 | 0.040 |
Why?
|
| Laser Therapy | 2 | 1992 | 151 | 0.040 |
Why?
|
| Glioma | 1 | 2002 | 321 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2002 | 503 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1176 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2024 | 441 | 0.040 |
Why?
|
| Olfaction Disorders | 1 | 2000 | 77 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 682 | 0.040 |
Why?
|
| Gene Expression | 1 | 2002 | 1319 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 569 | 0.030 |
Why?
|
| Chondroma | 1 | 1996 | 7 | 0.030 |
Why?
|
| Parietal Bone | 1 | 1996 | 17 | 0.030 |
Why?
|
| Frontal Bone | 1 | 1996 | 16 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 491 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2018 | 221 | 0.030 |
Why?
|
| Cerebral Ventricles | 2 | 1992 | 76 | 0.030 |
Why?
|
| Infant | 1 | 2022 | 3360 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 1999 | 1739 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2480 | 0.030 |
Why?
|
| Basilar Artery | 1 | 1993 | 40 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 1993 | 29 | 0.020 |
Why?
|
| Nerve Compression Syndromes | 1 | 1993 | 19 | 0.020 |
Why?
|
| Vertebral Artery | 1 | 1993 | 29 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 118 | 0.020 |
Why?
|
| Health Status | 1 | 2015 | 386 | 0.020 |
Why?
|
| Radiotherapy | 1 | 1995 | 325 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 3904 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 7215 | 0.020 |
Why?
|
| Peritoneum | 1 | 1992 | 55 | 0.020 |
Why?
|
| Glioblastoma | 2 | 2007 | 285 | 0.020 |
Why?
|
| Meningomyelocele | 1 | 1992 | 26 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 1993 | 122 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 2611 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 245 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2013 | 318 | 0.020 |
Why?
|
| Psychometrics | 1 | 2013 | 340 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1992 | 85 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1992 | 238 | 0.020 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1991 | 13 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1992 | 273 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 1992 | 244 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 1991 | 255 | 0.020 |
Why?
|
| Reoperation | 1 | 1992 | 707 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1991 | 579 | 0.020 |
Why?
|
| Personnel Turnover | 1 | 2008 | 11 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 883 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 1194 | 0.020 |
Why?
|
| Biopsy | 1 | 1991 | 1208 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2882 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2007 | 133 | 0.020 |
Why?
|
| Multigene Family | 1 | 2002 | 213 | 0.010 |
Why?
|
| Olfactory Nerve Injuries | 1 | 2000 | 1 | 0.010 |
Why?
|
| Head Injuries, Closed | 1 | 2000 | 12 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 701 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 897 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2015 | 10273 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 1957 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 1827 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 2575 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 2015 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 2061 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 3581 | 0.010 |
Why?
|
| Yttrium | 1 | 1992 | 3 | 0.010 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1992 | 28 | 0.010 |
Why?
|
| Cysts | 1 | 1992 | 104 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1992 | 212 | 0.010 |
Why?
|
| Equipment Design | 1 | 1992 | 427 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1992 | 1319 | 0.000 |
Why?
|